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Abstract 
A simple reverse-phase high performance liquid chromatographic method for the simultaneous analysis 
(separation and quantification) of furosemide (FURO), carbamazepine (CARB), diazepam (DIAZ) and carvedilol 
(CARV) has been developed and validated. The method was carried out on a NUCLEODUR® 100-5 C18ec column 
(250 x 4.6 mm, i. d.5µm), with a mobile phase comprising of acetonitrile: deionized water (50: 50 v/v, pH adjusted 
to 3.6 ±0.05 with acetic acid) at a flow rate 1.5 mL.min-1 and the quantification was achieved at 226 nm. The 
retention times of FURO, CARB, DIAZ and CARV were found to be 1.90 min, 2.79 min, 5.39 min and 9.56 min 
respectively. The method was validated in terms of linearity, accuracy, precision, limit of detection and limit of 
quantitation. The developed method was successfully applied for the estimation of furosemide, carbamazepine, 
diazepam and carvedilol in bulk and in pharmaceutical dosage forms.      
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1. Introduction 
Furosemide (FURO) is a loop diuretic mainly used for the treatment of hypertension and edema (Sarrafi et al. 
2010) chemically is 4-Chloro-2-[(furan-2-ylmethyl) amino]- 5-sulfamoylbenzoic acid.  
Carbamazepine (CARB) is a lipophilic tricyclic compound used in treatment of epilepsy and neuropathic 
pain (Moshé 2009) chemically it is 5H-dibenzo [b,f]azepine-5-carboxamide.  
Diazepam (DIAZ) chemically is 7-chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one 
and is used as anxiolytic, hypnotic and muscle relaxant (Calcaterra and Barrow 2014).  
Carvedilol (CARV) is a nonselective beta-blocker/ alpha-blocker antihypertensive agent, widely used in 
the treatment of hypertension, congestive heart failure, cardiac arrhythmia, and angina pectoris (Tapas et al. 2012) 
chemically it is (2RS)-1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy) ethyl] amino] propan-2-ol. Structural 
formulas of FURO, CARB, DIAZ and CARV are given in Figure 1. 
 
         
Diazepam                       Carbamazepine 
        
Carvedilol                      Furosemide 
Figure 1. The chemical structures of furosemide (FURO), carbamazepine (CARB), diazepam (DIAZ) and 
carvedilol (CARV).  
Review of literature revealed that a large number of analytical methods have been used to quantify CARV, 
FURO, CARB and DIAZ in their bulk and pharmaceutical formulations as well as in biological fluids including 
potentiometry (Ghorbani et al. 2014, Lee et al. 2014 and Soleymanpour & Ghasemian 2015), voltammetry (Pan 
et al. 2014, Hasanzadeh et al. 2014), GC-MS (Yilmaz & Arslan 2011, Zaporozhets et al.  2012 and Zhang et al. 
2014), flow injection technique (Biparva et al. 2014 and Han et al. 2013), spectrophotometry (Harshad & 
Sugandha 2015, Rad et al. 2014, Mohamed et al. 2014 and Tharpa et al.  2010) and high performance liquid 
chromatography (Thejaswini & Gurupadayya 2014, Elezovic et al. 2015, Soltani & Jouyban 2011 and Baranowska 
& Kowalski 2011).  
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2. Experimental 
2.1 Reagents and materials 
Furosemide, carbamazepine, diazepam, and carvedilol reference substances were obtained as gift samples from 
the State Company for Drug Industries and Medical Appliances Samara-Iraq (SDI). HPLC grade acetonitrile 
(99.9 %) was from Sigma Aldrich (Baghdad), HPLC grade water was obtained from ROMIL (Baghdad), and (99-
100%) acetic acid was purchased from Sigma Aldrich (Baghdad). 
Pharmaceutical formulations Lasix 40 mg/tablet (SWI, France and SDI, Iraq), Tegretol® 2% 
(NOVARTIS, Switzerland), Carbamazepine 200 mg/tablet (TAVER, Cyprus), VALIAPAM 2 mg / tablet (SDI, 
Iraq), Valiapam 10 mg / 2mL (ALSAVAL, Syria), Carvidol® 25 mg / tablet (Pharma International, India) and 
Carvedilol 6.25 mg / tablet (EMESSA, Syria) were obtained from local pharmacies. 
 
2.2 Instrumentation 
Shimadzu UFLC system (Kyoto, Japan) equipped with LC-20AD solvent delivery pump, SIL-20AC auto sampler 
unit, DGU-20A5 on-line vacuum degasser unit and a SPD-20A Shimadzu UV-Vis detector. Chromatographic 
analysis was performed on a NUCLEODUR® 100-5 C18 ec (250 × 4.6 mm i.d. 5µm particle) (MACHEREY-
NAGEL Germany) with isocratic conditions. The mobile phase consist of acetonitrile: deionized water (50: 50 v/v, 
pH adjusted to 3.6 ± 0.05 with acetic acid) at a flow rate of 1.5 mL.min-1 and the quantification was achieved at 
226 nm.   
 
2.3 Preparation of stock and working standard solutions 
1000 µg.mL-1 stock standard solutions of furosemide, carbamazepine and carvedilol were prepared separately in 
different 50 mL volumetric flasks by dissolving exactly 50 mg of each drug in acetonitrile, and diluted to the mark 
with acetonitrile. The stock solutions were protected from light and were stored at 4 ºC. Further dilution was done 
to get working standard solution (100 µg.mL-1) of each drug.  
 
2.4 Preparation of drugs in pharmaceutical formulations 
2.4.1 Tablets 
Ten tablets from each drug were separately weighed and powdered. A portion of the powder  equivalent to 0.0380 
g and 0.0400 g for Lasix (FURO) (Iraq, France) respectively, 0.3310 g and 0.1520 g for Carvedilol (CARV) (Syria, 
India) respectively, 0.0130 g for Carbamazepine (Cyprus) and 0.6010 g for Valiapam (DIAZ) (Iraq) were weighed, 
dissolved in about 8 mL of acetonitrile in a separate 10 mL volumetric flask. The solutions were sonicated for a 
minimum 10 min with intermittent shaking and diluted to mark with acetonitrile to get 1000 µg.mL-1. Then after, 
each solution was filtered through Whatman filter paper No. 41 and stored as the standard stock solutions for 
further dilution in subsequent use. 
2.4.2 Ampoule 
The 1000 µg.mL-1 Valiapam (DIAZ) solution was prepared by quantitatively transferring the content of 1 ampoule 
(10 mg /2 mL) to 10 mL volumetric flask, diluted to the mark with acetonitrile and stirred for 5 min for complete 
dissolution (mixing, homogenous) the drug. The resulted solution was filtered and further diluted with acetonitrile 
before its application to HPLC system for analysis. 
2.4.3 Oral suspension 
The content of one container of Tegretol (CARB) oral suspension (100 mg /5 mL) (2 %) was mixed well and 0.5 
mL of the suspension was quantitatively transferred into 10 mL volumetric flask and dissolved in 10 mL of 
acetonitrile, shaken well and sonicated for 5 min then made up to the mark with acetonitrile to get 1000 µg.mL-1. 
An aliquot of the resulted filtered solution was then treated as done in recommended procedure. 
 
2.5 Preparation of samples for linearity  
In order to ascertain that there is a direct proportional relationship between each analyte response and its 
concentration, mixture solutions containing different concentrations of FURO, CARB, CARV and DIAZ, were 
prepared by serial dilutions in a concentration rang of (1-100) µg.mL-1 for each of the studied drugs. 
 
3. Results and discussion 
3.1 RP-HPLC method 
The proper wavelength that gave approximately equal reasonable values of absorbance was selected by scanning 
the standard solutions of the four analytes (10 µg.mL-1 of each drug) in the wavelength range of 200 - 400 nm. 
Figure 2 shows the overlaid UV spectra of the four medications from which the wavelength 226 nm was chosen 
for the HPLC detection and quantitation of the cited drugs.  
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Figure 2. Overlaid UV spectra of the studied drugs (10 µg.mL-1) in acetonitrile against acetonitrile as a blank. 
Different mobile phases were tested to accomplish the simultaneous separation of the four analytes. A 
mobile phase consisting of acetonitrile: deionized water (50: 50 v/v, pH adjusted to 3.6 ±0.05 with acetic acid) 
was chosen for this purpose, after comparing the baselines, resolution and peak shapes under the various conditions. 
The most efficient separation was acheived by using a flow rate of 1.5 mL.min-1, column temperature of 40 oC, 
and injection volume of 10 µL, since it gave acceptable resolution values and reasonable analysis time. The 
developed method was found to be rapid as FURO, CARB, DIAZ, CARV eluted out at 1.90, 2.79, 5.39, and 9.56 
minutes respectively and the. The descriptive chromatogram of mixed standard solution of FURO, CARB, DIAZ 
(20 µg.mL-1 for each) and CARV (40 µg.mL-1) is shown in Figure 3. 
 
Figure 3. Chromatogram of standard solution of FURO, CARB, DIAZ and CARV. 
 
3.2 Linearity and range 
To determine the linearity of the proposed method, a series of mixed standard solutions of FURO, CARB, DIAZ 
and CARV were prepared and 10 µL of each solution was injected into the HPLC system. Calibration curves were 
obtained by plotting concentration (µg.mL-1) vs. peak area and peak height for FURO, CARB, DIAZ and CARV 
(Figure 4).  
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Figure 4. Calibration curves, concentration (µg.mL-1) vs. peak area and peak height for FURO, CARB, DIAZ 
and CARV. 
The linearity range, regression equation, correlation coefficient, limit of detection and limit of 
quantitation are given in Table 1. 
Table 1. Linearity parameters for FURO, CARB, DIAZ and CARV assay method. 
Drug 
Linearity 
range 
(µg.mL-1) 
Calibration 
curve 
r Slope Intercept 
LOD* 
(µg.mL-1) 
LOQ+ 
(µg.mL-1) 
FURO 1-100 
Peak area 0.9999 24115 260 0.115 0.348 
Peak height 1.0000 1337 55 0.074 0.225 
CARB 2.5-100 
Peak area 0.9998 15322 9144 0.210 0.636 
Peak height 0.9998 812 362 0.171 0.519 
DIAZ 2.5-100 
Peak area 0.9976 29103 75906 0.475 1.440 
Peak height 0.9991 570 823 0.462 1.399 
CARV 5-100 
Peak area 0.9977 20615 27413 0.950 2.877 
Peak height 0.9988 171 12 0.528 1.599 
 
3.3 Accuracy and precision 
Accuracy of the RP-HPLC method was tested by determining the values of relative error percentage (RE %) and 
the precision was evaluated by calculating the values of relative standard deviation percentage (RSD %) of the 
obtained results for the studied drugs. Three replicate analyses were carried out for each drug at two different 
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levels of concentrations within the linearity range for each drug. The obtained results indicate good accuracy and 
precision of the recommended procedure at the studied concentration levels (Table 2). 
Table 2. Accuracy and precision of the RP-HPLC method. 
Drug 
Injected 
(µg.mL-1) 
Calculated Conc. using peak area Calculated Conc. from peak height 
Mean* RSD% RE% Mean* RSD% RE% 
FURO 
20 19.9346 1.167 -0.327 20.221 0.7229 1.107 
80 81.056 0.9628 1.32 80.96 0.9732 1.2 
CARB 
20 19.8258 1.5263 -0.871 19.054 1.5356 -4.729 
80 78.4613 1.5018 -1.923 82.664 1.1275 3.33 
DIAZ 
20 19.0398 2.0011 -4.801 20.339 2.7821 1.6951 
80 79.2053 2.6548 -0.993 80.754 1.3357 0.9429 
CARV 
20 19.3214 3.9056 -3.393 20.981 2.2751 4.9066 
80 81.3142 3.0715 1.6428 81.93 1.9848 2.4127 
*Average of three measurements. 
 
4. Application 
The quantitative determination of FURO, CARB, DIAZ and CARV in commercially available pharmaceutical 
preparations (tablets, syrup and ampoule) was carried out following the proposed HPLC procedure. The 
Representative chromatogram of mixed pharmaceutical solution of FURO, CARB, DIAZ (20 µg.mL-1 for each) 
and CARV (40 µg.mL-1) is shown in Figure 5.  
 
Figure 5. Representative chromatogram of FURO, CARB, DIAZ and CARV in pharmaceutical formulations. 
Two concentration levels for each drug were separately injected in triplicate into the HPLC system and 
analyzed under the optimum conditions. The obtained values of recovery percentage (Tables 3 and 4) revealed the 
reliability of the recommended method for the determination of the cited drugs in their pharmaceutical 
formulations. 
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Table 3. Estimation of FURO, CARB, DIAZ and CARV in their pharmaceutical preparations via peak area. 
Sample 
Conc. (µg.mL-1) Calculated Conc. using  peak area 
Taken    Found 
Weight* found 
(mg/dosage) 
Recovery % RSD % 
FURO  (Iraq)  
tablet 40 mg 
20 21.313 42.622 106.6 1.628 
80 83.845 41.923 104.8 1.247 
FURO  (France)  
tablet 40 mg 
20 20.453 40.906 102.3 1.201 
80 82.699 41.349 103.4 1.080 
CARB  (Cyprus) 
 tablet 200 mg 
20 19.493 194.930 97.5 1.131 
80 78.570 196.425 98.2 1.294 
CARB (Switzerland)  
syrup 100 mg 
20 19.355 96.775 96.8 1.075 
80 75.325 94.156 94.2 0.987 
DIAZ (Iraq)  
tablet 2 mg 
20 20.339 2.034 101.7 1.548 
80 78.693 1.967 98.4 1.066 
DIAZ (Syria)  
ampoule10mg 
20 20.304 10.152 101.5 1.267 
80 82.323 10.290 102.9 0.942 
CARV (Syria)  
tablet 6.25 mg 
20 21.277 6.649 106.4 2.348 
80 83.279 6.506 104.1 2.075 
CARV (India) 
 tablet 25 mg 
20 18.467 23.084 92.3 2.540 
80 74.885 23.402 93.6 1.774 
*Average of three measurements. 
 
Table 4. Estimation of FURO, CARB, DIAZ and CARV in their pharmaceutical preparations via peak height. 
Sample 
Conc. (µg.mL-1) Calculated Conc. using peak height 
Taken   Found 
Weight* found 
(mg/dosage) 
Recovery % RSD % 
FURO (Iraq) 
tablet 40 mg 
20 19.850 39.700 99.3 1.447 
80 82.408 41.204 103.0 1.070 
FURO (France) 
tablet 40 mg 
20 20.289 40.578 101.4 0.698 
80 78.004 39.002 97.5 0.681 
CARB (Cyprus) 
tablet 200 mg 
20 18.807 188.070 94.0 1.043 
80 74.803 187.008 93.5 1.237 
CARB (Switzerland)  
syrup 100 mg 
20 18.240 91.201 91.2 1.008 
80 71.024 88.780 88.8 0.946 
DIAZ (Iraq) 
tablet 2 mg 
20 21.503 2.150 107.5 1.282 
80 77.565 1.940 96.9 1.040 
DIAZ (Syria) 
ampoule10mg 
20 20.995 10.498 105.0 1.147 
80 77.480 9.685 96.9 0.931 
CARV (Syria) 
tablet 6.25 mg 
20 21.315 6.661 106.6 2.696 
80 85.010 6.641 106.3 1.680 
CARV (India) 
tablet 25 mg 
20 20.449 25.561 102.2 2.304 
80 75.070 23.460 93.8 1.307 
*Average of three measurements. 
 
5. Conclusion 
This study describes a simple, rapid, precise and accurate RP-HPLC method for the simultaneous identification 
and quantification of FURO, CARB, DIAZ and CARV in bulk and pharmaceutical preparations as well. The 
suggested method gave acceptable resolution between the four compounds in a short period below 10 minutes and 
can be applied for analysis of regular quality control samples of the investigated drugs. 
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